ADC Scores 'Impressive' Survival Win in Heavily Pretreated Gastroesophageal Cancer

Summary
(MedPage Today) -- Overall survival (OS) in heavily pretreated gastroesophageal carcinoma (GEC) doubled in patients who received an investigational antibody-drug conjugate (ADC) targeting claudin (CLDN) 18.2, a randomized trial showed. Patients...
Description from Medpagetoday.
Who is covering this
-
ADC Scores 'Impressive' Survival Win in Heavily Pretreated Gastroesophageal Cancer
(MedPage Today) -- Overall survival (OS) in heavily pretreated gastroesophageal carcinoma (GEC) doubled in patients who received an investigational antibody-drug conjugate (ADC) targeting claudin (CLDN) 18.2, a randomized trial showed. Patients...